Skip to main content
SpringerLink
Log in

Growth hormone, prolactin, and sexuality

  • Review Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

GH and PRL, although not considered as ‘classi cal’ sexual hormones, could play a role in the endocrine control of sexual function both in men and women. Physiologically, PRL seems to be involved in the central control of sexual behavior and activity, by modulating mainly the effects of dopaminergic and serotoninergic systems on sexual function. Indeed, circulating PRL levels increase after orgasm and may potentially play a role in the acute regulation of further sexual arousal following orgasm both in men and women. On the other hand, either short-term or long-term PRL in crease can modulate central nervous system areas involved in the control of sexual function and, peripherally, can directly influence mechanisms of penile erection in men, and presently only as an hypothesis, mechanisms related to the sexual response of genitalia in women. Furthermore, chronic hyperprolactinemia is classically associated with hypogonadotropic hypogonadism and sexual dysfunction in both sexes. Successful treatment of chronic hyperprolactinemia generally restores normal sexual function both in men and women although this effect is not only related to relapse of gonadal function. Hypoprolactinemia is recently recognised as a possible risk factor of arteriogenic erectile dysfunction while a possible role on female sexual function is not known. The physiological role of GH on sexual function is not fully elucidated. GH is an important regulator of hypothalamus-pituitary-gonadal axis and seems to participate in the regulation of the sexual response of genitalia in men, and potentially also in women. Sexual function in men and women with GH deficiency (GHD) and GH excess, particularly in acromegaly, is scantily studied and GH- or IGF-I-dependent effects are difficult to quantify. Nevertheless, a decrease of desire and arousability both in men and women, together with an impairment of erectile function in men, have been described both in patients with GHD and acromegaly, although it is not clear whether they are dependent directly on the hormone defect or excess or they are consequence of the hypogonadism or the different clinical complications or the physical disfigurement and psychological imbalance, which are associated with the diseases, and are potentially affecting sexual function. Data on beneficial effects of GH replacement therapy and specific surgical or pharmacological approach for acromegaly are far to be fully elucidated although restoring normal GH/IGF-I levels have been associated to improvement of sexual function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bancroft J. The endocrinology of sexual arousal. J Endocrinol 2005, 186: 411–27.

    Article  CAS  PubMed  Google Scholar 

  2. Genazzani AR, Gastaldi M, Bidzinska B, et al. The brain as a target organ of gonadal steroids. Psichoneuroendocrinology 1992, 17: 385–90.

    Article  CAS  Google Scholar 

  3. Goffin V, Binart N, Touraine P, Kelly PA. Prolactin: the new biolo gy of an old hormone. Annu Rev Physiol 2002, 64: 47–67.

    Article  CAS  PubMed  Google Scholar 

  4. Roky R, Paut-Pagano L, Goffin V, et al. Distribution of prolactin re ceptors in the forebrain: immunohistochemical study. Neuroendocrinology 1996, 63: 422–9.

    Article  CAS  PubMed  Google Scholar 

  5. Hair WM, Gubbay O, Jabbour HN, Lincoln GA. Prolactin receptor expression in human testisand accessory tissues: localization and function. Mol Hum Reprod 2002, 8: 606–11.

    Article  CAS  PubMed  Google Scholar 

  6. Saito T, Saxena BB. Specific receptors for prolactin in the ovary. Acta Endocrinol (Copenh) 1975, 80: 126–37.

    Article  CAS  Google Scholar 

  7. Jones RL, Critchley HO, Brooks J, Jabbour HN, McNeilly AS. Localization and temporal expression of prolactin receptor in hu man endometrium. J Clin Endocrinol Metab 1998, 83: 258–62.

    Article  CAS  PubMed  Google Scholar 

  8. Shao R, Nutu M, Weijdegård B, et al. Differences in prolactin re ceptor (PRLR) in mouse and human fallopian tubes: evidence for multiple regulatory mechanisms controlling PRLR isoform expres sion in mice. Biol Reprod 2008, 79: 748–57.

    Article  CAS  PubMed  Google Scholar 

  9. Rowland DL, Heiman JR, Gladue BA, Hatch JP, Doering CH, Weiler SJ. Endocrine, psychological and genital response to sexual arousal in men. Psychoneuroendocrinology 1987, 12: 149–58.

    Article  CAS  PubMed  Google Scholar 

  10. Stoléru SG, Ennaji A, Cournot A, Spira A. LH pulsatile secretion and testosterone blood levels are influenced by sexual arousal in human males. Psychoneuroendocrinology 1993, 18: 205–18.

    Article  PubMed  Google Scholar 

  11. Carani C, Bancroft J, Del Rio G, Granata ARM, Facchinetti F, Marrama P. The endocrine effects of visual erotic stimuli in normal men. Psychoneuroendocrinology 1990, 15: 207–16.

    Article  CAS  PubMed  Google Scholar 

  12. Purvis K, Landgren BM, Cekan Z, Diczfalusy E. Endocrine effects of masturbation in men. J Endocrinol 1976, 70: 439–44.

    Article  CAS  PubMed  Google Scholar 

  13. Krüger TH, Haake P, Chereath D, et al. Specificity of the neuroen docrine response to orgasm during sexual arousal in men. J Endo crinol 2003, 177: 57–64.

    Article  Google Scholar 

  14. Exton NG, Truong TC, Exton MS, et al. Neuroendocrine response to film-induced sexual arousal in men and women. Psychoneuroen docrinology 2000, 25: 189–99.

    Article  Google Scholar 

  15. Exton MS, Krüger THC, Koch M, et al. Coitus-induced orgasm stim ulated prolactin secretion in healthy subjects. Psychoneuroendo crinology 2001, 26: 287–94.

    Article  CAS  Google Scholar 

  16. Krüger TH, Hartmann U, Schedlowski M. Prolactinergic and dopaminergic mechanisms underlying sexual arousal and orgasm in hu mans. World J Urol 2005, 23: 130–8.

    Article  PubMed  CAS  Google Scholar 

  17. Drago F, Lissandrello CO. The “low dose” concept and the para doxical effects of prolactin on grooming and sexual behavior. Eur J Pharmacol 2000, 405: 131–7.

    Article  CAS  PubMed  Google Scholar 

  18. Cruz-Casallas PE, Nasello AG, Hucke EE, Felicio LF. Dual modula tion of male sexual behavior in rats by central prolactin: relationship with in vivo striatal dopaminergic activity. Psychoneuroendo crinology 1999, 24: 681–93.

    Article  CAS  Google Scholar 

  19. Nasello AG, Vanzeler ML, Madureira EH, Felicio LF. Effects of acute and long term domperidone treatment on prolactin and gonadal hormone levels and sexual behavior of male and female rats. Pharmacol Biochem Behav 1997, 58: 1089–94.

    Article  CAS  PubMed  Google Scholar 

  20. Krüger TH, Haake P, Haverkamp J, et al. Effects of acute prolactin manipulation on sexual drive and function in males. J Endocrinol 2003, 179: 357–65.

    Article  PubMed  Google Scholar 

  21. Corona G, Jannini EA, Lotti F, et al. Premature and delayed ejac ulation: two ends of a single continuum influenced by hormonal milieu. Int J Androl 2010, 33: 41–8.

    Google Scholar 

  22. Haake P, Exton MS, Haverkamp J, et al. Absence of orgasm in duced prolactin secretion in a healthy multi-orgasmic subject. Int J Impot Res 2002, 14: 133–5.

    Article  CAS  PubMed  Google Scholar 

  23. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev 2000, 80: 1523–631.

    Article  CAS  PubMed  Google Scholar 

  24. DeMaria JE, Lerant AA, Freeman ME. Prolactin activates all three populations of hypothalamic neuroendocrine dopaminergic neu rons in ovariectomized rats. Brain Res 1999, 837: 236–41.

    Article  CAS  PubMed  Google Scholar 

  25. Björklund A, Moore RY, Nobin A, Stenevi U. The organization of tubero-hypophyseal and reticulo-infundibular catecholamine neu ron systems in the rat brain. Brain Res 1973, 51: 171–91.

    Article  PubMed  Google Scholar 

  26. Goudreau JL, Lindley SE, Lookingland KJ, Moore KE. Evidence that hypothalamic periventricular dopamine neurons innervate the intermediate lobe of the rat pituitary. Neuroendocrinology 1992, 56: 100–5.

    Article  CAS  PubMed  Google Scholar 

  27. Ganong WF. Circumventricular organs: definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharma col Physiol 2000, 27: 422–7.

    Article  CAS  Google Scholar 

  28. Sobrinho LG. The psychogenic effects of prolactin. Acta Endocrinol (Copenh) 1993, 129: 38–40.

    Google Scholar 

  29. Hull EM, Lorraine DS, Du J, et al. Hormone-neurotransmitter in teractions in the control of sexual behavior. Behav Brain Res 1999, 105: 105–16.

    Article  CAS  PubMed  Google Scholar 

  30. Mas M. Neurobiological correlates of masculine sexual behavior. Neurosci Biobehav Rev 1995, 19: 261–77.

    Article  CAS  PubMed  Google Scholar 

  31. Pi XJ, Grattan DR. Differential expression of the two forms of pro lactin receptor mRNA within microdissected hypothalamic nuclei of the rat. Brain Res Mol Brain Res 1998, 59: 1–12.

    Article  CAS  PubMed  Google Scholar 

  32. Lookingland KJ, Moore KE. Effects of estradiol and prolactin on incertohypothalamic dopaminergic neurons in the male rat. Brain Res 1984, 323: 83–91.

    Article  CAS  PubMed  Google Scholar 

  33. Bradley K, Meisel RL. Sexual behavior induction of c-Fos in the nu cleus accumbens and amphetamine-stimulated locomotor activi ty are sensitized by previous sexual experience in female Syrian hamsters. J Neurosci 2001, 21: 2123–30.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Gonzalez-Mora JL, Guadalupe T, Mas M. In vivo voltammetry study of the modulatory action of prolactin on mesolimbic dopaminergic system. Brain Res Bull 1990, 25: 729–33.

    Article  CAS  PubMed  Google Scholar 

  35. Chen JC, Ramirez VD. In vivo dopaminergic activity from the nu cleus accumbens, substantia niagra and ventral tegmental area in the freely moving rat: basal neurochemical output and prolactin effect. Neuroendocrinology 1988, 48: 329–35.

    Article  CAS  PubMed  Google Scholar 

  36. Robbins TW, Everitt BJ. Functions of dopamine in the dorsal and ventral striatum. Sem Neurosci 1992, 4: 119–28.

    Article  Google Scholar 

  37. Chen JC, Ramirez VD. Effects of prolactin on tyrosine hydroxylase activity of central dopaminergic neurons of male rats. Eur J Pharmacol 1989, 166: 473–9.

    Article  CAS  PubMed  Google Scholar 

  38. Cebeira M, Hernandez ML, Rodriguez de Fonseca F, de Miguel R, Fernandez-Ruiz JJ, Ramos JA. Lack of effect of prolactin on the dopaminergic receptor sensitivity of striatal and limbic areas after experimentally-induced alterations in peripheral levels. Life Sci 1991, 48: 531–41.

    Article  CAS  PubMed  Google Scholar 

  39. Pfaus JG. Pathways of sexual desire. J Sex Med 2009, 6: 1506–33.

    Article  CAS  PubMed  Google Scholar 

  40. DeMaria JE, Zelena D, Vecsernyés M, Nagy GM, Freeman ME. The effect of neurointermediate lobe denervation on hypothalamic neuroendocrine dopaminergic neurons. Brain Res 1998, 806: 89–94.

    Article  CAS  PubMed  Google Scholar 

  41. Aoki H, Fujioka T, Matsuzaka J, Kubo T, Nakamura K, Yasuda N. Suppression by prolactin of the electrically induced erectile re sponse through its direct effect on the corpus cavernosum penis in the dog. J Urol 1995, 154: 595–600.

    Article  CAS  PubMed  Google Scholar 

  42. Ra S, Aoki H, Fujioka T, Sato F, Kubo T, Yasuda N. In vitro con traction of the canine corpus cavernosum penis by direct perfusion with prolactin or growth hormone. J Urol 1996, 156: 522–5.

    Article  CAS  PubMed  Google Scholar 

  43. Andersson KE, Wagner G. Physiology of penile erection. Physiol Rev 1995, 75: 191–236.

    Article  CAS  PubMed  Google Scholar 

  44. Romano-Torres M, Phillips-Farfán BV, Chavira R, Rodríguez-Manzo G, Fernández-Guasti A. Relationship between sexual satiety and brain androgen receptors. Neuroendocrinology 2007, 85: 16–26.

    Article  CAS  PubMed  Google Scholar 

  45. Finley SK, Kritzer MF. Immunoreactivity for intracellular androgen receptors in identified subpopulations of neurons, astrocytes and oligodendrocytes in primate prefrontal cortex. J Neurobiol 1999, 40: 446–57.

    Article  CAS  PubMed  Google Scholar 

  46. Carani C, Granata ARM, Faustini Fustini M, Marrama P. Prolactin and testosterone: their role in male sexual function. Int J Androl 1996, 19: 48–54.

    Article  CAS  PubMed  Google Scholar 

  47. Meisel RL, Sachs BD. The physiology of male sexual behavior. In: Knobil E, Neill JD (eds). The Physiology of Reproduction. New York: Raven Press. 1994, 3–105.

    Google Scholar 

  48. Melis MR, Argiolas A. Dopamine and sexual behavior. Neurosci Biobehav Rev 1995, 19: 19–38.

    Article  CAS  PubMed  Google Scholar 

  49. Doherty PC, Wu DE, Matt KS. Hyperprolactinemia preferentially inhibits erectile function in adrenalectomized male rats. Life Sci 1990, 47: 141–8.

    Article  CAS  PubMed  Google Scholar 

  50. Doherty PC, Lane SJ, Pfeil KA, Morgan WW, Bartke A, Smith MS. Extra-hypothalamic dopamine is not involved in the effects of hy perprolactinemia on male copulatory behavior. Physiol Behav 1989, 45: 1101–5.

    Article  CAS  PubMed  Google Scholar 

  51. Doherty PC, Bartke A, Smith MS, Davis SL. Increased serum pro lactin levels mediate the suppressive effects of ectopic pituitary grafts on copulatory behavior in male rats. Horm Behav 1985, 19: 111–21.

    Article  CAS  PubMed  Google Scholar 

  52. Bailey DJ, Dolan AL, Pharoah PD, Herbert J. Role of gonadal and adrenal steroids in the impairment of the male rat’s sexual be haviour by hyperprolactinaemia. Neuroendocrinology 1984, 39: 555–62.

    Article  CAS  PubMed  Google Scholar 

  53. Bartke A, Doherty PC, Steger RW, et al. Effects of estrogen-in duced hyperprolactinemia on endocrine and sexual functions in adult male rats. Neuroendocrinology 1984, 39: 126–35.

    Article  CAS  PubMed  Google Scholar 

  54. Kalra PS, Simpkins JW, Luttge WG, Kalra SP. Effects on male sex behavior and preoptic dopamine neurons of hyperprolactinemia induced by MtTW15 pituitary tumors. Endocrinol 1983, 113: 2065–71.

    Article  CAS  Google Scholar 

  55. Dudley CA, Jamison TS, Moss RL. Inhibition of lordosis behavior in the female rat by intraventricular infusion of prolactin and by chron ic hyperprolactinemia. Endocrinol 1982, 110: 677–9.

    Article  CAS  Google Scholar 

  56. Drago F. Prolactin and sexual behavior: a review. Neurosci Biobehav Rev 1984, 8: 433–9.

    Article  CAS  PubMed  Google Scholar 

  57. Sato F, Aoki H, Nakamura K, Taguchi M, Aoki T, Yasuda N. Sup pressive effects of chronic hyperprolactinemia on penile erection and yawning following administration of apormorphine to pituitary-transplanted rats. J Androl 1997, 18: 21–5.

    CAS  PubMed  Google Scholar 

  58. Aoki H, Fujioka T, Matsuzaka J, Kubo T, Nakamura K, Yasuda N. Suppression by prolactin of the electrically induced erectile re sponse through its direct effect on the corpus cavernosum penis in the dog. J Urol 1995, 154: 595–600.

    Article  CAS  PubMed  Google Scholar 

  59. Mangurian LP, Walsh RJ, Posner BI. Prolactin enhancement of its own uptake at the choroid plexus. Endocrinology 1992, 131: 698–702.

    CAS  PubMed  Google Scholar 

  60. MohanKumar PS, MohanKumar SM, Arbogast L, Quadri SK, Voogt JL. Effects of chronic hyperprolactinemia on tuberoinfundibular dopaminergic neurons. Proc Soc Exp Biol Med 1998, 217: 461–5.

    Article  CAS  PubMed  Google Scholar 

  61. Paradisi R, Grossi G, Pintore A, Venturoli S, Porcu E, Capelli M. Evi dence for a pathological reduction in brain dopamine metabolism in idiopathic hyperprolactinemia. Acta Endocrinol 1991, 125: 246–52.

    Article  CAS  Google Scholar 

  62. Hull EM, Bitran D, Pehek EA, Warner RK, Band LC, Holmes GM. Dopaminergic control of male sex behavior in rats: effects of a intracerebrally-infused agonist. Brain Res 1986, 73–81.

  63. Buvat J, Lemaire A, Buvat-Herbaut M, Fourlinnie JC, Racadot A, Fossati P. Hyperprolactinemia and sexual function in men. Horm Res 1985, 22: 196–203.

    Article  CAS  PubMed  Google Scholar 

  64. Mas M, Fumero B, González-Mora JL. Voltammetric and microdialysismonitoring of brain monoamine neurotransmitter release dur ing psychosexual interactions. Behav Brain Res 1995, 71: 69–79.

    Article  CAS  PubMed  Google Scholar 

  65. Bridges RS, Di Biase R, Loundes DD, Doherty PC. Prolactin stim ulation of maternal behavior in female rats. Science 1985, 227: 782–4.

    Article  CAS  PubMed  Google Scholar 

  66. Delavierre D, Girard P, Peneau M, Ibrahim H. Should plasma pro lactin assay be routinely performed in the assessment of erectile dysfunction? Report of a series of 445 patients. Review of the lit erature. Prog Urol 1999, 9: 1097–101.

    CAS  PubMed  Google Scholar 

  67. Buvat J. Hyperprolactinemia and sexual function in men: A short re view. Int J Impot Res 2003, 15: 373–7.

    Article  CAS  PubMed  Google Scholar 

  68. De Rosa M, Zarrilli S, Vitale G, et al. Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumes cence. J Clin Endocrinol Metab 2004, 89: 621–5.

    Article  PubMed  CAS  Google Scholar 

  69. Buvat J. Hormones and male sexual behavior: physiological and physiopathological data. Contr Fertil Sex 1996, 24: 767–78.

    CAS  Google Scholar 

  70. Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia an amenorrhea: responses to bromocriptine. J Clin Endocrinol Metab 1984, 59: 941–8.

    Article  CAS  PubMed  Google Scholar 

  71. Kadioglu P, Yalin AS, Tiryakioglu O, et al. Sexual dysfunction in women with hyperprolactinemia: a pilot study report. J Urol 2005, 174: 1921–5.

    Article  PubMed  Google Scholar 

  72. Koppelman MC, Parry BL, Hamilton JA, Alagna SW, Loriaux DL. Effect of bromocriptine on affect and libido in hyperprolactinemia. Am J Psychiatry 1987, 144: 1037–41.

    Article  CAS  PubMed  Google Scholar 

  73. Lobo RA, Kletzky OA. Normalization of androgen and sex hor mone-binding globulin levels after treatment of hyperprolactine mia. J Clin Endocr Metab 1982, 56: 562–6.

    Article  Google Scholar 

  74. Buvat J. Influence of primary hyperprolactinemia on human sexu al behavior. Nouv Presse Med 1982, 11: 3561–3.

    CAS  PubMed  Google Scholar 

  75. Walsh JP, Pullan PT. Hyperprolactinaemia in males: a heteroge neous disorder. Aust N Z J Med 1997, 27: 385–90.

    Article  CAS  PubMed  Google Scholar 

  76. De Rosa M, Zarrilli S, Di Sarno A, et al. Hyperprolactinemia in men: clinical and biochemical features and response to treatment. Endocrine 2003, 20: 75–82.

    Article  PubMed  Google Scholar 

  77. Colao A, Vitale G, Cappabianca P, et al. Outcome of cabergoline treatment in men with prolactinoma: effects of a 24-month treatment on prolactin levels, tumor mass, recovery of pituitary function, and semen analysis. J Clin Endocrinol Metab 2004, 89: 1704–11.

    Article  CAS  PubMed  Google Scholar 

  78. De Rosa M, Ciccarelli A, Zarrilli S et al. The treatment with cabergoline for 24 month normalizes the quality of seminal fluid in hyperprolactinaemic males. Clin Endocrinol (Oxf) 2006, 64: 307–13.

    Article  CAS  Google Scholar 

  79. Koppelman MC, Parry BL, Hamilton JA, Alagna SW, Loriaux DL. Effect of Bromocriptine on affect and libido in hyperprolactinemia. Am J Psychiatry 1987, 144: 1037–41.

    Article  CAS  PubMed  Google Scholar 

  80. De Rosa M, Colao A, Di Sarno A, et al. Cabergoline treatment rapid ly improves gonadal function in hyperprolactinemic males: a com parison with bromocriptine. Eur J Endocrinol 1998, 138: 286–93.

    Article  PubMed  Google Scholar 

  81. Soran H, Wu FC. Endocrine causes of erectile dysfunction. Int J Androl 2005, 28: 28–34.

    Article  CAS  PubMed  Google Scholar 

  82. Vermeulen A, Ando S, Verdonck L. Prolactinomas, testosteronebinding globulin and androgen metabolism. J Clin Endocr Metab 1982, 54: 409–13.

    Article  CAS  PubMed  Google Scholar 

  83. Colao A, Di Sarno A, Cappabianca P, et al. Gender differences in the prevalence, clinical features and response to cabergoline in hyperprolactinemia. Eur J Endocrinol 2003, 148: 325–31.

    Article  CAS  PubMed  Google Scholar 

  84. Buvat J, Lemaire A, Buvat-Herbaut M, Marcolin G. Prolactin de termination in impotence. Presse Med 1989, 18: 1167.

    CAS  PubMed  Google Scholar 

  85. Corona G, Mannucci E, Fisher AD, et al. Effect of hyperprolactine mia in male patients consulting for sexual dysfunction. J Sex Med 2007, 4: 1485–93.

    Article  CAS  PubMed  Google Scholar 

  86. Bhasin S, Enzlin P, Coviello A, Basson R. Sexual dysfunction in men and women with endocrine disorders Lancet 2007, 369: 597–611.

    Article  CAS  PubMed  Google Scholar 

  87. Corona G, Mannucci E, Jannini EA, et al. Hypoprolactinemia: a new clinical syndrome in patients with sexual dysfunction. J Sex Med 2009, 6: 1457–66.

    Article  CAS  PubMed  Google Scholar 

  88. Kopchick JJ, Andry JM. Growth hormone (GH), GH receptor, and signal transduction. Mol Genet Metab 2000, 71: 293–314.

    Article  CAS  PubMed  Google Scholar 

  89. Nyberg F. Growth hormone in the brain: characteristics of specif ic brain targets for the hormone and their functional significance. Front Neuroendocrinol 2000, 21: 330–48.

    Article  CAS  PubMed  Google Scholar 

  90. Lobie PE, Breipohl W, Aragón JG, Waters MJ. Cellular localization of the growth hormone receptor/binding protein in the male and female reproductive systems. Endocrinology 1990, 126: 2214–21.

    Article  CAS  PubMed  Google Scholar 

  91. Chandrashekar V, Zaczek D, Bartke A. The consequences of altered somatotropic system on reproduction. Biol Reprod 2004, 71: 17–27.

    Article  CAS  PubMed  Google Scholar 

  92. Daftary SS, Gore AC. IGF-1 in the brain as a regulator of repro ductive neuroendocrine function. Exp Biol Med (Maywood) 2005, 230: 292–306.

    Article  CAS  Google Scholar 

  93. Hull KL, Harvey S. Growth hormone: a reproductive endocrineparacrine regulator? Rev Reprod 2000, 5: 175–82.

    Article  CAS  PubMed  Google Scholar 

  94. Bellastella A, Esposito D, Conte M, et al. Sexuality in aging male. J Endocrinol Invest 2005, 28 (11 Suppl): 55–60.

    CAS  PubMed  Google Scholar 

  95. Becker AJ, Uckert S, Stief CG, et al. Serum levels of human growth hormone during different penile conditions in the cavernous and systemic blood of healthy men and patients with erectile dysfunc tion. Urology 2002, 59: 609–14.

    Article  PubMed  Google Scholar 

  96. Uckert S, Scheller F, Stief CG, et al. Potential mechanism of action of human growth hormone on isolated human penile erectile tissue. Urology 2010, 75: 968–73.

    Article  PubMed  Google Scholar 

  97. Dahiya R, Chui R, Perinchery G, Nakajima K, Oh BR, Lue TF. Differential gene expression of growth factors in young and old rat penile tissues is associated with erectile dysfunction. Int J Impot Res 1999, 11: 201–6.

    Article  CAS  PubMed  Google Scholar 

  98. Hamed EA, Meki AR, Gaafar AA, Hamed SA. Role of some vasoactive mediators in patients with erectile dysfunction: their rela tionship with angiotensin-converting enzyme and growth hormone. Int J Impot Res 2003, 15: 418–25.

    Article  CAS  PubMed  Google Scholar 

  99. Burnett AL, Calvin DC, Silver RI, Peppas DS, Docimo SG. Immunohistochemical description of nitric oxide synthase isoforms in hu man clitoris. J Urol 1997, 158: 75–8.

    Article  CAS  PubMed  Google Scholar 

  100. de Boer H, Blok GJ, Van der Veen EA. Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995, 16: 63–86.

    Article  PubMed  Google Scholar 

  101. McKenna S, Doward L, Alonso J, et al. The QoL-AGHDA: an in strument for the assessment of quality of life in adults with growth hormone deficiency. Qual. Life Res 1999, 8: 373–83.

    Article  CAS  PubMed  Google Scholar 

  102. Rosén T, Wirén L, Wilhelmsen L, Wiklund I, Bengtsson BA. De creased psychological well-being in adult patients with growth hor mone deficiency. Clin Endocrinol (Oxf) 1994, 40: 111–6.

    Article  Google Scholar 

  103. Rikken B, van Busschbach J, le Cessie S, et al. Impaired social sta tus of growth hormone deficient adults as compared to controls with short or normal stature. Dutch Growth Hormone Working Group. Clin Endocrinol (Oxf) 1995, 43: 205–11.

    Article  CAS  Google Scholar 

  104. Thomas JD, Monson JP. Adult GH deficiency throughout lifetime. Eur J Endocrinol 2009, 161: S97–106.

    Article  CAS  PubMed  Google Scholar 

  105. Attanasio AF, Shavrikova EP, Blum WF, Shalet SM. Quality of life in childhood onset growth hormone-deficient patients in the transition phase from childhood to adulthood. J Clin Endocrinol Metab 2005, 90: 4525–9.

    Article  CAS  PubMed  Google Scholar 

  106. Böger RH, Skamira C, Bode-Böger SM, Brabant G, von zur Muhlen A, Frolich JC. Nitric oxide may mediate the hemodynamic effects of recombinant growth hormone in patients with acquired growth hormone deficiency. J Clin Invest 1996, 98: 2706–13.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Tsukahara H, Gordienko DV, Tonshoff B, Gelato MC, Goligorsky MS. Direct demonstration of insulin-like growth factor-1-induced nitric oxide production by endothelial cells. Kidney Int 1994, 45: 598–604.

    Article  CAS  PubMed  Google Scholar 

  108. Menezes M, Salvatori R, Oliveira CR, et al. Climacteric in un treated isolated growth hormone deficiency. Menopause 2008, 15: 743–7.

    Article  PubMed  PubMed Central  Google Scholar 

  109. Hernberg-Ståhl E, Luger A, Abs R, et al; KIMS International Board; KIMS Study Group. Pharmacia International Metabolic Database. Healthcare consumption decreases in parallell with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. J Clin Endocrinol Metab 2001, 86: 5277–81.

    Article  PubMed  Google Scholar 

  110. Colao A, Di Somma C, Cuocolo A, et al. Does a gender-related ef fect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atheroscle rosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency. J Clin Endocrinol Metab 2005, 90: 5146–55.

    Article  CAS  PubMed  Google Scholar 

  111. Gibney J, Wallace J, Spinks T et al. The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient pa tients. J Clin Endocrinol Metab 1999, 84: 2596–602.

    Article  CAS  PubMed  Google Scholar 

  112. Carani C, Granata AR, De Rosa M, et al. The effect of chronic treat ment with GH on gonadal function in men with isolated GH defi ciency. Eur J Endocrinol 1999, 140: 224–30.

    Article  CAS  PubMed  Google Scholar 

  113. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in men over 60 years old. N Engl J Med 1990, 323: 1–6.

    Article  CAS  PubMed  Google Scholar 

  114. Colao A, Ferone D, Marzullo P, Lombardi G. Systemic complica tions of acromegaly: epidemiology, pathogenesis, and manage ment. Endocr Rev 2004, 25: 102–52.

    Article  CAS  PubMed  Google Scholar 

  115. Jadresic A, Banks LM, Child DF, et al. The acromegaly syndrome. Q J Med 1982, 202: 189–204.

    Google Scholar 

  116. Lombardo F, Gandini L, Jannini EA, et al. Diagnosing erectile dys function: instruments for endocrine diagnosis. Int J Androl 2005, 28(Suppl 2): 53–5.

    Article  PubMed  Google Scholar 

  117. Balercia G, Boscaro M, Lombardo F, Carosa E, Lenzi A, Jannini EA. Sexual symptoms in endocrine diseases: psychosomatic perspec tives. Psychother Psychosom 2007, 76: 134–40.

    Article  PubMed  Google Scholar 

  118. Bartke A, Meliska C, Milton S, et al. Effects of overexpression of different growth hormone genes on male reproductive functions in transgenic mice. In: Kula K, Slowikowska-Hilczer J, eds. Hormonal Control of Spermatogenesis: Basic and Clinical Aspects. Cracow, Poland: Polish Andrology Society and International Society of Andrology. 1997: 1–15.

    Google Scholar 

  119. Webb, SM, Prieto L, Badia X, et al. Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psy chometric properties. Clin Endocrinol 2002, 57: 251–8.

    Article  CAS  Google Scholar 

  120. McVary KT. Erectile dysfunction. N Engl J Med 2007, 357: 2472–81.

    Article  CAS  PubMed  Google Scholar 

  121. Brevetti G, Marzullo P, Silvestro A, et al. Early vascular alteration in acromegaly. J Clin Endocrinol Metab 2002, 87: 3175–9.

    Article  Google Scholar 

  122. Maison P, Démolis P, Young J, Schaison G, Giudicelli JF, Chanson P. Vascular reactivity in acromegalic patients: preliminary evidence for regional endothelial dysfunction and increased sympathetic vasoconstriction. Clin Endocrinol (Oxf) 2000, 53: 445–51.

    Article  CAS  Google Scholar 

  123. Galdiero M, Vitale P, Grasso L, et al. Evaluation of male sexual function in active acromegalic patients before and after disease remission: Preliminary study. 2012, Abstract book International/European Congress of Endocrinology. Poster n.1395.

  124. Galdiero M, Vitale P, Grasso L, et al. Evaluation of ejaculatory function in acromegalic men: preliminary study. 2012, Abstract book International/European Congress of Endocrinology, Poster n.1394.

  125. Colao A, De Rosa M, Pivonello R, et al. Short-term suppression of GH and IGF-I levels improves gonadal function and sperm param eters in men with acromegaly. J Clin Endocrinol Metab 2002, 87: 4193–7.

    Article  CAS  PubMed  Google Scholar 

  126. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner MO. Recent ad vances in pathogenesis, diagnosis and management of acromeg aly. J Clin Endocrinol Metab 1995, 80: 3395–402.

    CAS  PubMed  Google Scholar 

  127. Kaltsas GA, Mukherjee JJ, Jenkins PJ, et al. Menstrual irregularity in women with acromegaly. J Clin Endocrinol Metab 1999, 84: 2731–5.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Molecular & Clinical Endocrinology and Oncology, “Federico II” University of Naples, Via S. Pansini 5, 80131, Naples, Italy

    M. Galdiero, R. Pivonello MD, PhD, L. F. S. Grasso, A. Cozzolino & A. Colao

Authors
  1. M. Galdiero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. Pivonello MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. L. F. S. Grasso
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Cozzolino
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Colao
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Pivonello MD, PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Galdiero, M., Pivonello, R., Grasso, L.F.S. et al. Growth hormone, prolactin, and sexuality. J Endocrinol Invest 35, 782–794 (2012). https://doi.org/10.1007/BF03345805

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03345805

Key-words

Search

Navigation